Rob Lozuk
Chief Business Officer
Rob and his team are responsible for the Innovation Partnership Program (IPP) at Cardea. In the past decade alone, Rob served as Thermo Fisher’s Director of Business Development and Americas Marketing, and as Senior Vice President of Commercial Operations at Sequenom, a groundbreaker in genomic testing in the now rapidly growing noninvasive prenatal testing market. In 2016, Sequenom was successfully transacted to LabCorp. Most recently, Rob was President of Specific Diagnostics, a private Silicon Valley based company focused on microbiology.